Natick, MA, United States of America

Hyun Chong Woo

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 12.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Brookline, MA (US) (2013)
  • Natick, MA (US) (2015 - 2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Hyun Chong Woo: Innovator in Spleen Tyrosine Kinase Inhibition

Introduction

Hyun Chong Woo is a distinguished inventor based in Natick, MA, USA, known for his significant contributions to the field of medicinal chemistry. With a total of seven patents to his name, he has made noteworthy advancements in developing compounds aimed at treating diseases mediated by Spleen Tyrosine Kinase (Syk).

Latest Patents

Among his latest patents, Hyun Chong Woo has developed innovative compounds including thiazole-substituted aminoheteroaryls and thiazole-substituted aminopyridines. The first patent details compounds of a specific formula, along with their pharmaceutically acceptable salts. These compounds demonstrate potential for use in pharmaceutical compositions targeting conditions associated with Spleen Tyrosine Kinase. Similarly, his second patent focuses on thiazole-substituted aminopyridines, providing compounds with similar medicinal applications aimed at Syk-mediated diseases.

Career Highlights

Throughout his career, Woo has garnered experience working at prominent pharmaceutical companies such as Merck Sharp & Dohme Corporation and Merck Canada Inc. His work in these organizations has been pivotal to his research and innovation in drug development, specifically in relation to cancer therapies.

Collaborations

Hyun Chong Woo has collaborated with notable colleagues, including Matthew Christopher and Joon Jung. These partnerships have likely enriched his research endeavors, promoting the advancement of innovative solutions in the pharmaceutical sector.

Conclusion

Hyun Chong Woo's innovative work continues to contribute to the field of medicine, particularly in developing treatments that target critical pathways in disease management. His dedication to research and collaboration exemplifies the spirit of innovation that propels advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…